Cipla hits 52-week high as company seeks DCGI nod to import Moderna#39;s COVID jab Dayanand Saini | June 30, 2021 | Stocks News | No Comments The firm submitted its application to the drugs regulator on June 28, CNBC TV-18 has reported. Related Posts Buzzing Stocks: Bob, Aurobindo Pharma, PNB, Divis Labs and others that will be in focus today No Comments | May 31, 2021 P and G Standalone December 2020 Net Sales at Rs 1,018.44 crore, up 18.52% Y-o-Y No Comments | Feb 4, 2021 MM Forgings Consolidated March 2021 Net Sales at Rs 293.36 crore, up 74.09% Y-o-Y No Comments | Jun 24, 2021 Deploy Nifty call butterfly spread strategy this Diwali week: Shubham Agarwal No Comments | Nov 1, 2021 About The Author Dayanand Saini